Cybrexa Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors (NCT04902872) | Cybrexa Therapeutics | 2021-05-03 |
Track Cybrexa Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.